Recognizing our Heroes of Chemistry

Since 1996, the ACS Heroes of Chemistry program has recognized chemical scientists whose work in various fields of chemistry and chemical engineering has led to the successful innovation and development of commercial products based on chemistry. The Heroes of Chemistry program highlights the vital role of industrial chemical scientists and their companies in improving human welfare through successful commercial innovations and products. It presents an ideal opportunity to enhance the public image of the chemical and allied industries.

Each year, Heroes of Chemistry are nominated by their own companies to recognize their talent, creativity, and innovation. Our previous Heroes of Chemistry have excelled in innovation at prominent international corporations and developed many commercial products that demonstrate strong financial performance. The commercial success of their products in the marketplace is an important criterion for this honor, because we recognize that good business results follow good science.

Learn more about Heroes of Chemistry

Deadline for 2013 nominations is Friday, April 12, 2013.

• Heroes of Chemistry Call For Nominations
• Heroes of Chemistry Nomination Form
• View a list of past recipients.

2012 Heroes of Chemistry

http://web.2.c3.audiovideoweb.com/il80web20030/heroesofchemistry/Arkema_480p.mp4

In this video, Georg Lindner, Connie Lo, Clem McKown, Jing Ming Mai, Jeremy Nihart, Dave Russo, Ryan Smith and Jeff Stricker, a team of scientists from Arkema, are recognized for the scientific discovery, technical development, and commercial implementation of Atmospheric Pressure Chemical Vapor Deposition technology in the production of high performance window glass.

http://web.2.c3.audiovideoweb.com/il80web20030/heroesofchemistry/Merck_480p.mp4

In this video, Ashok Arasappan, Frank Bennett, Stéphane Bogen, F. George Njoroge and Srikanth Venkatraman, a team of scientists from Merck, are recognized for the discovery and development of Victrelis^TM, a first-in-class treatment for the Hepatitis C virus.

http://web.2.c3.audiovideoweb.com/il80web20030/heroesofchemistry/Novartis_480p.mp4

In this video, Werner Breitenstein, Gabriele Fendrich, Sandra Jacob and Paul Manley, a team of scientists from Novartis, are recognized for the discovery and development of Tasigna^®, a leading treatment for Chronic Myeloid Leukemia.

• 2012 Press Conference
• 2012 Press Release